Leuprorelin (Leuprolide) EP Impurity H is a structural variant used to benchmark analytical specificity in leuprolide testing. Its altered sequence influences chromatographic mobility and solution conformation. Researchers rely on it for impurity quantification and structural verification. Applications include process development, stability testing, and LC-MS method refinement.
CAT No: Z10-101-197
Synonyms/Alias:(S)-N-ethyl-1-(((S)-5-oxopyrrolidine-2-carbonyl)-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-D-leucyl-L-arginyl)pyrrolidine-2-carboxamide
Leuprorelin (Leuprolide) EP Impurity H is a synthetic peptide impurity structurally related to leuprorelin, a well-characterized luteinizing hormone-releasing hormone (LHRH) analog. As a defined process-related impurity, it arises during the synthesis or degradation of leuprorelin and is of significant interest in peptide chemistry and pharmaceutical quality control. Its precise identification and characterization are critical for ensuring the consistency, safety, and efficacy of peptide-based active pharmaceutical ingredients (APIs). The availability of this impurity as a reference material supports the rigorous analytical demands of peptide research, enabling scientists and quality professionals to evaluate product purity, process optimization, and impurity profiling.
Analytical Method Development: Leuprorelin (Leuprolide) EP Impurity H serves as a crucial reference standard in the development and validation of analytical methods for peptide drug substances. Its defined structure enables chromatographers and analytical chemists to establish robust high-performance liquid chromatography (HPLC) or mass spectrometry (MS) protocols capable of separating and quantifying structurally similar impurities. By incorporating this impurity into method development workflows, laboratories can ensure their assays meet stringent specificity, sensitivity, and reproducibility requirements, supporting regulatory compliance and batch release testing.
Impurity Profiling and Characterization: The presence of Leuprorelin (Leuprolide) EP Impurity H is a key parameter in the impurity profiling of leuprorelin and related peptide therapeutics. Researchers utilize this impurity to identify, quantify, and monitor trace-level byproducts arising from peptide synthesis, storage, or degradation processes. Detailed characterization of such impurities allows for a comprehensive understanding of the impurity landscape, contributing to risk assessment, product safety evaluation, and the establishment of impurity limits in accordance with pharmacopeial guidelines.
Peptide Synthesis Optimization: In peptide manufacturing, the identification and quantification of process-related impurities like Leuprorelin (Leuprolide) EP Impurity H provide critical feedback for process optimization. Synthetic chemists can use the impurity as a marker to evaluate the efficiency of purification steps, assess the impact of reaction conditions, and refine synthetic routes. This approach enables continuous improvement in peptide synthesis protocols, ultimately supporting the production of high-quality peptide APIs with minimal impurity content.
Stability Studies: The inclusion of Leuprorelin (Leuprolide) EP Impurity H in forced degradation and stability studies is essential for understanding the degradation pathways of leuprorelin and related peptides. By tracking the formation and behavior of this impurity under various stress conditions, researchers gain valuable insights into the chemical stability and shelf life of peptide formulations. Such studies inform the design of storage conditions, packaging solutions, and shelf-life specifications, ensuring product integrity throughout its lifecycle.
Quality Control and Batch Release Testing: Routine use of Leuprorelin (Leuprolide) EP Impurity H as a system suitability standard or spiking agent in quality control laboratories supports the accurate quantification of impurities in peptide drug substances and finished products. Its presence allows for the calibration and verification of analytical instruments, ensuring that impurity levels remain within acceptable limits. This practice is fundamental to maintaining product consistency, meeting regulatory expectations, and safeguarding the quality of peptide-based pharmaceuticals during manufacturing and release.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More